Zobrazeno 1 - 10 of 288 pro vyhledávání: '"Thomas M, Pisansky"'
1
Akademický článek
Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials
Autor: Andre Esteva, Jean Feng, Douwe van der Wal, Shih-Cheng Huang, Jeffry P. Simko, Sandy DeVries, Emmalyn Chen, Edward M. Schaeffer, Todd M. Morgan, Yilun Sun, Amirata Ghorbani, Nikhil Naik, Dhruv Nathawani, Richard Socher, Jeff M. Michalski, Mack Roach, Thomas M. Pisansky, Jedidiah M. Monson, Farah Naz, James Wallace, Michelle J. Ferguson, Jean-Paul Bahary, James Zou, Matthew Lungren, Serena Yeung, Ashley E. Ross, NRG Prostate Cancer AI Consortium, Howard M. Sandler, Phuoc T. Tran, Daniel E. Spratt, Stephanie Pugh, Felix Y. Feng, Osama Mohamad
Publikováno v: npj Digital Medicine, Vol 5, Iss 1, Pp 1-8 (2022)
Abstract Prostate cancer is the most frequent cancer in men and a leading cause of cancer death. Determining a patient’s optimal therapy is a challenge, where oncologists must select a therapy with the highest likelihood of success and the lowest l
Externí odkaz: https://doaj.org/article/54fe1e7fc7644b949b66c889805f2d44
Zobrazit plný text záznamu
3
Akademický článek
Comparing bowel and urinary domains of patient‐reported quality of life at the end of and 3 months post radiotherapy between intensity‐modulated radiotherapy and proton beam therapy for clinically localized prostate cancer
Autor: Miao Bai, Kimberly R. Gergelis, Mustafa Sir, Thomas J. Whitaker, David M. Routman, Bradley J. Stish, Brian J. Davis, Thomas M. Pisansky, Richard Choo
Publikováno v: Cancer Medicine, Vol 9, Iss 21, Pp 7925-7934 (2020)
Abstract Purpose To prospectively assess acute differences in patient‐reported outcomes in bowel and urinary domains between intensity‐modulated radiotherapy (IMRT) and proton beam therapy (PBT) for prostate cancer. Methods and Materials Bowel fu
Externí odkaz: https://doaj.org/article/4c0e6024a1cb41bd87863fb3b80feb89
Zobrazit plný text záznamu
4
Akademický článek
Single-fraction Stereotactic Body Radiation Therapy versus Conventionally Fractionated Radiation Therapy for the Treatment of Prostate Cancer Bone Metastases
Autor: Robert W. Gao, BS, Kenneth R. Olivier, MD, Sean S. Park, MD, PhD, Brian J. Davis, MD, PhD, Thomas M. Pisansky, MD, Richard Choo, MD, Eugene D. Kwon, MD, R. Jeffrey Karnes, MD, William S. Harmsen, MS, Bradley J. Stish, MD
Publikováno v: Advances in Radiation Oncology, Vol 4, Iss 2, Pp 314-322 (2019)
Purpose: This study aimed to compare outcomes of patients with prostate cancer with bone metastases treated with stereotactic body radiation therapy (SBRT) versus conventionally fractionated radiation therapy (CFRT). Methods and materials: An institu
Externí odkaz: https://doaj.org/article/b17ba1bc1e814446ba90aa29e72e224c
Zobrazit plný text záznamu
6
Akademický článek
Mapping expanded prostate cancer index composite to EQ5D utilities to inform economic evaluations in prostate cancer: Secondary analysis of NRG/RTOG 0415.
Autor: Rahul Khairnar, Stephanie L Pugh, Howard M Sandler, W Robert Lee, Ester Villalonga Olives, C Daniel Mullins, Francis B Palumbo, Deborah W Bruner, Fadia T Shaya, Soren M Bentzen, Amit B Shah, Shawn C Malone, Jeff M Michalski, Ian S Dayes, Samantha A Seaward, Michele Albert, Adam D Currey, Thomas M Pisansky, Yuhchyau Chen, Eric M Horwitz, Albert S DeNittis, Felix Y Feng, Mark V Mishra
Publikováno v: PLoS ONE, Vol 16, Iss 4, p e0249123 (2021)
PurposeThe Expanded Prostate Cancer Index Composite (EPIC) is the most commonly used patient reported outcome (PRO) tool in prostate cancer (PC) clinical trials, but health utilities associated with the different health states assessed with this tool
Externí odkaz: https://doaj.org/article/28c81274f9f04bb1953d4d523b5584d0
Zobrazit plný text záznamu
9
Biochemical Failure Is Not a Surrogate End Point for Overall Survival in Recurrent Prostate Cancer: Analysis of NRG Oncology/RTOG 9601
Autor: William C. Jackson, Ming Tang, Matthew J. Schipper, Howard M. Sandler, Zachary S. Zumsteg, Jason A. Efstathiou, William U. Shipley, Wendy Seiferheld, Himanshu R. Lukka, Jean-Paul Bahary, Anthony L. Zietman, Thomas M. Pisansky, Kenneth L. Zeitzer, William A. Hall, Robert T. Dess, Richard D. Lovett, Alexander G. Balogh, Felix Y. Feng, Daniel E. Spratt
Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 40(27)
PURPOSE Metastasis-free survival (MFS), but not event-free survival, is a validated surrogate end point for overall survival (OS) in men treated for localized prostate cancer. It remains unknown if this holds true in biochemically recurrent disease a
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eeab4ef580c30a45c538da00ddfd7b61
https://pubmed.ncbi.nlm.nih.gov/35737923
Zobrazit plný text záznamu
10
A Phase II prospective study of hypofractionated proton therapy of prostate and pelvic lymph nodes: Acute effects on patient‐reported quality of life
Autor: William W. Wong, David W. Hillman, Thomas B. Daniels, Carlos E. Vargas, Jean Claude Rwigema, Kimberly S. Corbin, Sameer R. Keole, Kenneth W. Merrell, Bradley J. Stish, Thomas M. Pisansky, Brian J. Davis, Cecilia M. Mitchell, Richard Choo
Publikováno v: The Prostate. 82:1338-1345
The objective of this study was to report acute changes in patient-reported quality of life (PRQOL) using the 26-item Expanded Prostate Index Composite (EPIC-26) questionnaire in a prospective study using hypofractionated intensity-modulated proton b
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6b9b940b257f0d92a817407e85e9c04
https://doi.org/10.1002/pros.24408
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje